Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype
| Status: | Completed |
|---|---|
| Conditions: | Cancer, Cancer, Other Indications |
| Therapuetic Areas: | Oncology, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | March 2014 |
| End Date: | July 2015 |
This study tests the efficacy of an 8-week, Skype-based, group resiliency training
intervention (The Relaxation Response Resiliency Program) for improving psychological stress
in patients with Neurofibromatosis. A control group will receive a general health education
curriculum. The investigators hypothesize that patients will improve on measures of
psychological stress as a result of the resiliency program.
intervention (The Relaxation Response Resiliency Program) for improving psychological stress
in patients with Neurofibromatosis. A control group will receive a general health education
curriculum. The investigators hypothesize that patients will improve on measures of
psychological stress as a result of the resiliency program.
Inclusion Criteria:
1. Age 18 or older
2. Can read and speak English at or above the 6th grade level
3. Diagnosis of neurofibromatosis type 1, neurofibromatosis type 2, or schwannomatosis
Exclusion Criteria:
1. Severe active or untreated major mental illness that would interfere with study
participation, to be determined at the discretion of the study investigator (e.g.
untreated psychosis or suicidality)
2. Recent (within past 3 months) change in antidepressant medication
3. Use of formal relaxation training (including past participation in a mind-body
program), currently or in the past 6 months.
4. Unable or unwilling to sign the informed consent documents
5. Unable or unwilling to complete psychological assessments online via the REDCap
system.
6. Unable or unwilling to participate in an intervention delivered via videoconferencing
with Skype.
We found this trial at
1
site
Click here to add this to my saved trials
